Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT05037500 2025-11-12

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Phase 1 Terminated

8 enrolled

Genitourinary

Prostatic Neoplasms

NCT03734653 2025-11-06

Testosterone Therapy in Castration Resistant Prostate Cancer

Phase EARLY_PHASE1 Completed

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT04335682 2025-11-04

ARACOG

Phase 2 Active not recruiting

111 enrolled

Genitourinary

Prostatic Neoplasms

NCT06844383 2025-10-29

TALENT

Phase 2 Recruiting

126 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT03939689 2025-10-14

ARROW

Phase 2 Completed

120 enrolled 21 charts

Genitourinary

Prostatic Neoplasms

NCT04557449 2025-10-01

CDK4i

Phase 2 Active not recruiting

362 enrolled

BreastGastrointestinalGenitourinarySarcomaThoracic

Adenocarcinoma of Lung, Breast Neoplasms, Liposarcoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT05081193 2025-09-22

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Phase 2 Completed

15 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

MK-5684-004

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

MEVPRO-1

PREDICT

MEVPRO-3

A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer

ARCH

Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

Tivozanib + Enzalutamide in Adv Prostate Cancer

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

AMX-500

AcTFirst

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

CASPAR

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

rechARge

PROSPER

CheckMate 9KD

A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer

EvoPAR-PR01

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

TRIPLE-SWITCH

SPLASH

STEEL

DIVINE

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

CONTACT-02

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Testosterone Therapy in Castration Resistant Prostate Cancer

ARACOG

TALENT

ARROW

CDK4i

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer